Market News & Trends
Pharma 4.0 – A New Initiative to Help Design the Pharma Facility of the Future
The pharma industry is continuously evolving which creates value for both the industry itself and the patients that rely on the ever-more varied and targeted drugs it manufacturers. An initiative that is strongly reflective of this evolution and one actively affecting the industry itself is Pharma 4.0.
Haselmeier & Common Sensing Enter Connected Injectable Medicine Collaboration
Haselmeier and Common Sensing recently announced a partnership agreement to develop smart connected monitoring and support solutions for users of injectable medicines. Worldwide, over 16 billion injections of medicine are administered every year. Smart connected monitoring solutions for users of injectables is aimed helping them to properly administer those medicines to improve efficacy and quality of therapies.
AMRI Expands NMR Spectroscopy Capabilities
AMRI recently announced it will expand its nuclear magnetic resonance (NMR) spectroscopy capabilities in Europe with the addition of the Bruker AVANCE NEO 600 MHz…
Catalent Announces Organizational Restructuring to Support Customer Demand for Fast, Integrated Biologics Development
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced key organizational changes…
Porton Pharma Solutions & Codexis Launch Global Partnership
Codexis, Inc and Porton Pharma Solutions, Ltd. recently announced a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active…
ARCA biopharma & Medtronic Extend Gencaro Clinical Trial Collaboration Agreement
ARCA biopharma, Inc. recently announced that Medtronic, Inc. has extended the US, Canadian, and European Clinical Trial Collaboration Agreement with ARCA for an additional year…
Q Therapeutics Announces Joint Venture With REPROCELL
Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) diseases, and REPROCELL Inc., Japan’s first induced pluripotent stem cell (iPSC)…
Bormioli Pharma Addresses Drug Stability & Value-Added Medicines With Packaging Innovation
Bormioli Pharma, one of the world’s leading glass and plastic packaging manufacturers for the pharmaceutical sector, offers its innovative dual-chamber AccuRec system as a solution…
Amerigen & Dipharma Announce Approval of First Generic of Miglustat
Amerigen Pharmaceuticals Limited and Dipharma S.A. recently announced that Amerigen’s Abbreviated New Drug Application (ANDA) for Miglustat 100 mg capsules has received final approval from…
Emisphere Amends License Agreement with Novo Nordisk; Will Receive $7 Million
Emisphere Technologies, Inc. recently announced that it has amended its existing 2015 Development and License Agreement with Novo Nordisk A/S for the development and commercialization of…
Roquette: Bringing New Solutions for Biotherapeutics
Protein stabilization is a critical challenge facing biotherapeutic formulators due to a multitude of destabilizing forces and pathways. The complexity and natural propensity of proteins…
Noramco & SPI Pharma Sign Agreement to Develop Ready-to-Implement, Patient-Friendly Formulations
Noramco and SPI Pharma recently announced the two companies have signed an agreement to develop and license a set of “value-added” formulation packages for global…
Catalent to Invest $5 Million at Somerset Site to Create New Drug Development & Modified Release Center of Excellence
Catalent Pharma Solutions recently announced it plans to invest $5 million in the creation of a new drug development center of excellence (CoE) at its…
Synteract Repositions Itself With Centers of Therapeutic Development & Unveils Updated Brand Platform
Synteract recently announced the creation of therapeutic centers of development that include some of the most progressive in the biopharma industry: oncology, especially leading-edge immunotherapy…
Carpe Secures $2.3 Million to Fight Hyperhidrosis
Carpe, a skincare startup offering over-the-counter relief for excessive hand and foot sweating to the estimated 365 million hyperhidrosis sufferers worldwide, recently announced it has…
New Preclinical Studies Reinforce the Potential for Heightened Anti-Cancer Activity of Combination Therapies Based on Immunovaccine’s Proprietary Delivery Platform
Immunovaccine Inc. recently announced that it presented new research on its T-cell activating platform at the American Association for Cancer Research (AACR) Annual Meeting 2018.…
Organovo Achieves Key Development Milestones
Organovo Holdings, Inc. recently announced that along with its collaborators, it has achieved several breakthrough capabilities for its 3D bioprinted tissues. At the International Liver Congress,…
Kineta to Collaborate on the Development of a Novel Non-Opioid Pain Therapy With Genentech
Kineta Chronic Pain, LLC, a subsidiary of Kineta, Inc., recently announced it has entered into an exclusive option and license agreement with Genentech, a member…
Foamix Announces $16 Million Investment by OrbiMed
Foamix Pharmaceuticals Ltd. recently announced it has raised aggregate gross proceeds of approximately $16 million through a direct registered offering of its ordinary shares to OrbiMed. On…
WuXi AppTec Expands Site in the United States for Drug Development Testing Services
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, recently announced the opening of its expanded Laboratory Testing Division…
